Sharemaestro Newsreel

Clover Health (CLOV) CEO sells 62,711 shares for RSU tax withholding

Clover Health Investments CEO Andrew Toy sold 62,711 Class A shares at a weighted average price of $4.67 per share. This mandatory "sell to cover" transaction was executed to fulfill tax withholding obligations tied to the vesting of 6.25% of his restricted stock units …

Clover Health Investments (CLOV) legal chief sells shares in tax-cover transaction

Clover Health Investments' Chief Legal Officer, Karen Soares, sold 10,519 shares of Class A common stock at a weighted average price of $4.67 per share on July 15, 2026. This transaction was to cover tax withholding obligations from the vesting of restricted stock units …

Clover Health (NASDAQ: CLOV) insider sale covers RSU tax obligations

Clover Health insider Wai Conrad sold 24,215 Class A shares on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a non-discretionary "sell to cover" transaction to satisfy tax withholding obligations from the vesting of 6.25% of his …

Alignment Healthcare (NASDAQ: ALHC) president trades 177K shares, exercises options

Alignment Healthcare's president, Dawn Christine Maroney, exercised options for 152,068 shares at $9.06 per share and subsequently sold 177,068 shares at a weighted-average price of $20.8281 per share under a Rule 10b5-1 trading plan. The transactions, which occurred on July 15, 2026, resulted in …

Form 4 Progyny Inc For: 16 July By Investing.com

This article is a brief financial report titled "Form 4 Progyny Inc For: 16 July

Progyny, Inc. (PGNY) COO trades stock: 2,244 shares sold, 1,193 for taxes

Progyny, Inc.'s Chief Operating Officer, Melissa B. Cummings, reported insider transactions including the sale of 2,244 shares at $31.60 each under a pre-arranged Rule 10b5-1 trading plan. Additionally, 1,193 shares were disposed of to cover withholding taxes related to the vesting of restricted stock …

Progyny stock hits 52-week high at 32.59 USD

Progyny Inc. (PGNY) has reached a 52-week high of $32.59, marking a 102% surge from its 52-week low and a 40.55% 1-year change, indicating strong investor confidence. Despite this, InvestingPro analysis suggests the company may be undervalued, and it recently authorized a $200 million …

3rd Circ. Partly Revives Hospitals' ERISA Suit Against Cigna

The Third Circuit Court of Appeals has partially revived an ERISA lawsuit filed by a New Jersey hospital network against Cigna. The court reinstated some contract claims alleging Cigna underpaid out-of-network reimbursements by $114 million, while upholding the dismissal of the network's fiduciary duty …

Baker Hughes Company completed the acquisition of Chart Industries, Inc..

Baker Hughes Company has completed its acquisition of Chart Industries, Inc. for $10.1 billion, as initially agreed upon in July 2025. The transaction was funded through a combination of cash on hand and debt issuance. Following the merger, Chart Industries will become a wholly-owned …

Lobbying Update: $180,000 of MOLINA HEALTHCARE INC. lobbying was just disclosed

Molina Healthcare Inc. (MOH) recently disclosed $180,000 in lobbying expenditures for Q2 2026, focusing on Medicare Advantage, Medicaid, and Marketplace tax credits. Insider trading activity for MOH shows more sales than purchases over the past six months. Additionally, institutional investors have increased their holdings, …

Cigna Group stock underperforms Thursday when compared to competitors

Shares of Cigna Group (CI) fell 4.70% on Thursday, closing at $283.82, in a trading session where the broader market also saw declines. This marked the third consecutive day of losses for the stock, underperforming the S&P 500 Index and the Dow Jones Industrial …

Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now

Alignment Healthcare (ALHC) is poised for growth due to its strong balance sheet and significant investments in automation and AI, which are enhancing operational efficiency and expanding margins. However, the company faces near-term challenges from the transition to the CMS V28 risk adjustment model …

UnitedHealth Group Q2: The Real Test Begins Now (Downgrade) (NYSE:UNH)

UnitedHealth Group (UNH) reported a strong Q2 with a 50% YoY operating income increase and raised its FY 2026 EPS guidance to $19.5–$20, driven by effective cost initiatives and AI growth. Despite these operational improvements, the stock's valuation now exceeds its 5-year average P/E, …

CION Investment Corporation Enters into Note Purchase Agreements for Up to $10 Million 7.50% Senior Unsecured Notes Due 2029 and Up to $50 Million 8.00% Senior Unsecured Notes Due 2031

CION Investment Corporation has entered into agreements to issue up to $10 million in 7.50% senior unsecured notes due 2029 and up to $50 million in 8.00% senior unsecured notes due 2031. The initial closing on July 15, 2026, totaled $30 million, comprising $2 …

Unitedhealth Group Inc Stock (UNH) Moved Up by 4.61% on Jul 16: Key Drivers Unveiled

UnitedHealth Group Inc. (UNH) stock rose by 4.61% on July 16, driven by a strong second-quarter earnings report that exceeded Wall Street expectations. The company's effective management of its Medical Care Ratio and an upward revision of its full-year earnings guidance reassured investors and …

RBC Lowers Price Target on Elevance Health to $424 From $439, Keeps Sector Perform Rating

RBC Capital Markets has reduced its price target for Elevance Health (ELV) to $424 from $439, while maintaining a Sector Perform rating on the stock. This adjustment comes despite the firm keeping its rating, indicating a revised outlook on the company's valuation.

Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance

Elevance Health (ELV) stock sharply declined despite beating revenue estimates and raising its full-year guidance. The market reacted negatively due to a significant drop in operating margins, particularly in its core Health Benefits segment, driven by higher medical costs in government businesses. Management views …

Centene (CNC) Stock Sees Modest Fair Value Lift As Analysts Back Earnings Recovery

Centene (CNC) has received a modest fair value uplift from US$61.83 to US$63.78, reflecting analysts' more constructive view on its earnings power. While some analysts are bullish due to favorable trends in exchanges, Medicare Advantage, and Medicaid margin recovery, others maintain neutral ratings due …

Molina Healthcare options signal 11% move on earnings day By Investing.com

Molina Healthcare Inc. (MOH) shares are anticipated to move by 11% following its earnings report on July 23, according to options data. Historically, the stock has exceeded its implied move in half of its last eight earnings announcements. For instance, in April 2022, it …

Humana stock hits 52-week high at 424.0 USD By Investing.com

Humana Inc. (NYSE: HUM) stock has reached a new 52-week high of $424, marking an 82.41% increase over the past year and indicating strong investor confidence. Despite trading near its peak with an RSI suggesting it's overbought, InvestingPro analysis indicates the stock may still …

The Medicaid Problem Weighing On Elevance Health Stock

Elevance Health's stock is performing strongly, yet its large Medicaid division is a significant drag due to an unprofitable operating margin. The company's strategy includes exiting some Medicaid markets, which, while mitigating losses, also shrinks its revenue base and addressable market. This presents a …

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Following its Q2 earnings report, Elevance Health (NYSE: ELV) exceeded analyst expectations, prompting several analysts to revise their forecasts. The company reported adjusted earnings of $7.45 per share and revenue of $49.83 billion, both above consensus estimates, leading to a raised full-year guidance for …

UnitedHealth reports quarterly profit above Wall Street estimates

UnitedHealth reported its second-quarter earnings, exceeding Wall Street's profit estimates. The article, authored by Ike Swetlitz from Bloomberg, highlights the strong financial performance of the healthcare giant. This report indicates a positive quarter for UnitedHealth.

UnitedHealthcare recovery in swing but challenges remain

UnitedHealth Group reported a rise in earnings, primarily driven by the slow recovery of its UnitedHealthcare division. Despite this positive trend, the company still faces significant challenges in its operational landscape. The article highlights that while progress is being made, the path to full …

UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results

UnitedHealth Group (NYSE:UNH) reported stronger-than-expected Q2 results, leading to a 5% share climb in post-market trading and an increased full-year adjusted earnings outlook. The company's adjusted earnings of $6.38 per share and revenue of $112 billion surpassed analyst expectations. UnitedHealth attributed its success to …

Baird Adjusts Price Target on Elevance Health to $393 From $331, Maintains Neutral Rating

Baird has adjusted its price target for Elevance Health (ELV) to $393, up from $331, while reiterating a Neutral rating on the stock. This update reflects a change in the analyst's valuation for the health insurance company. The article also lists several other firms …

Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets

Elevance Health reported stronger-than-expected Q2 results and raised its full-year guidance, leading to a positive market reaction. The company plans to exit underperforming Medicaid markets while focusing on expanding Medicare Advantage and Carelon health services, signaling a shift in its capital allocation and operational …

UnitedHealth blasts health care providers’ ‘egregious’ awards under No Surprises Act

UnitedHealth Group is criticizing the No Surprises Act's arbitration process, claiming health care providers are receiving "egregious" and inflated awards, significantly driving up costs for employer health plans. The company highlights instances where surgical assistants allegedly received payments far exceeding standard rates, adding billions …

UnitedHealth regains earnings momentum, shares surge

UnitedHealth rallies on upbeat forecast; these ETFs have the highest exposure (UNH:NYSE)

UnitedHealth Group (UNH) has raised its full-year profit outlook after exceeding Wall Street's second-quarter earnings expectations. The company now forecasts adjusted earnings of $19.50 to $20.00 per share for 2025, an increase from its previous guidance, signaling a sustained recovery after a significant setback. …

UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs

UnitedHealth Group (UNH) significantly surpassed Q2 earnings estimates and raised its full-year profit outlook for 2026, benefiting from better management of high medical costs and a $1.5 billion investment in AI. The company reported adjusted earnings of $6.38 per share, against an expected $4.90, …

What's Behind Centene's Recent Stock Plunge

Centene's stock plunged 15.97% despite a 2026 profit outlook exceeding analyst expectations, driven by deep market concerns over increasing medical costs, "Obamacare headwinds" from a sicker ACA Marketplace population, and intensified regulatory scrutiny in Medicaid and Medicare Advantage. The company is facing challenges with …

Agilon Health (AGL) Rallies On AI Care Narrative As Valuation Questions Linger

Agilon Health (AGL) has seen a recent surge in share price, leading investors to re-evaluate its Medicare-focused model and financial metrics, with analysts suggesting an AI care narrative is driving the rally. Despite a 130.2% one-year return, the stock is considered overvalued by many, …

Press Release: Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance

Elevance Health announced strong results for the second quarter of 2026, with earnings per share and adjusted earnings per share exceeding expectations. The company also reported significant revenue growth and raised its full-year guidance for 2026, indicating continued positive momentum.

Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2

Elevance Health is reducing its Medicaid business, exiting the Washington D.C. market effective August 1, and plans to leave additional challenging Medicaid markets over the next 18 months, executives announced. This decision stems from struggles to achieve sustainable performance due to low state payment …

Cigna Group stock holds steady as a major U.S. health insurer with diversified benefits business

Cigna Group's stock reflects its standing as a major U.S. health insurer and benefits provider, offering a diversified portfolio that includes commercial and government health plans, pharmacy benefits, and international services. The company's strategy emphasizes diversification across these segments, combining traditional insurance with service-based …